IL28B, HLA-C and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a european cohort: A cross-sectional study

V Suppiah; Silvana Gaudieri; NJ Armstrong; KS O'Connor; T Berg; M Weltman; ML Abate; U Spengler; M Bassendine; GJ Dore; W Irving; E Powell; M Hellard; S Riordan; G Matthews; D Sheridan; J Nattermann; A Smedile; T Muller; E Hammond; D Dunn; F Negro; P Bochud; S Mallal; G Ahlenstiel; GJ Stewart; J George; DR Booth

doi:10.1371/journal.pmed.1001092

IL28B, HLA-C and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a european cohort: A cross-sectional study

V Suppiah, Silvana Gaudieri, NJ Armstrong, KS O'Connor, T Berg, M Weltman, ML Abate, U Spengler, M Bassendine, GJ Dore, W Irving, E Powell, M Hellard, S Riordan, G Matthews, D Sheridan, J Nattermann, A Smedile, T Muller, E HammondD Dunn, F Negro, P Bochud, S Mallal, G Ahlenstiel, GJ Stewart, J George, DR Booth

Research output: Contribution to journal › Article › peer-review

99 Citations (Scopus)

Original language	English
Pages (from-to)	1-8
Journal	PLoS Medicine
Volume	8
Issue number	9
DOIs	https://doi.org/10.1371/journal.pmed.1001092
Publication status	Published - 2011

Access to Document

10.1371/journal.pmed.1001092

Cite this

Suppiah, V., Gaudieri, S., Armstrong, NJ., O'Connor, KS., Berg, T., Weltman, M., Abate, ML., Spengler, U., Bassendine, M., Dore, GJ., Irving, W., Powell, E., Hellard, M., Riordan, S., Matthews, G., Sheridan, D., Nattermann, J., Smedile, A., Muller, T., ... Booth, DR. (2011). IL28B, HLA-C and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a european cohort: A cross-sectional study. PLoS Medicine, 8(9), 1-8. https://doi.org/10.1371/journal.pmed.1001092

Suppiah, V ; Gaudieri, Silvana ; Armstrong, NJ ; O'Connor, KS ; Berg, T ; Weltman, M ; Abate, ML ; Spengler, U ; Bassendine, M ; Dore, GJ ; Irving, W ; Powell, E ; Hellard, M ; Riordan, S ; Matthews, G ; Sheridan, D ; Nattermann, J ; Smedile, A ; Muller, T ; Hammond, E ; Dunn, D ; Negro, F ; Bochud, P ; Mallal, S ; Ahlenstiel, G ; Stewart, GJ ; George, J ; Booth, DR. / IL28B, HLA-C and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a european cohort: A cross-sectional study. In: PLoS Medicine. 2011 ; Vol. 8, No. 9. pp. 1-8.

@article{ca4e834463f64ca79f07a4e4f8663f8f,

title = "IL28B, HLA-C and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a european cohort: A cross-sectional study",

author = "V Suppiah and Silvana Gaudieri and NJ Armstrong and KS O'Connor and T Berg and M Weltman and ML Abate and U Spengler and M Bassendine and GJ Dore and W Irving and E Powell and M Hellard and S Riordan and G Matthews and D Sheridan and J Nattermann and A Smedile and T Muller and E Hammond and D Dunn and F Negro and P Bochud and S Mallal and G Ahlenstiel and GJ Stewart and J George and DR Booth",

year = "2011",

doi = "10.1371/journal.pmed.1001092",

language = "English",

volume = "8",

pages = "1--8",

journal = "PLoS Medicine",

issn = "1549-1277",

publisher = "Public Library of Science (PLoS)",

number = "9",

}

Suppiah, V, Gaudieri, S, Armstrong, NJ, O'Connor, KS, Berg, T, Weltman, M, Abate, ML, Spengler, U, Bassendine, M, Dore, GJ, Irving, W, Powell, E, Hellard, M, Riordan, S, Matthews, G, Sheridan, D, Nattermann, J, Smedile, A, Muller, T, Hammond, E, Dunn, D, Negro, F, Bochud, P, Mallal, S, Ahlenstiel, G, Stewart, GJ, George, J & Booth, DR 2011, 'IL28B, HLA-C and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a european cohort: A cross-sectional study', PLoS Medicine, vol. 8, no. 9, pp. 1-8. https://doi.org/10.1371/journal.pmed.1001092

IL28B, HLA-C and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a european cohort: A cross-sectional study. / Suppiah, V; Gaudieri, Silvana; Armstrong, NJ; O'Connor, KS; Berg, T; Weltman, M; Abate, ML; Spengler, U; Bassendine, M; Dore, GJ; Irving, W; Powell, E; Hellard, M; Riordan, S; Matthews, G; Sheridan, D; Nattermann, J; Smedile, A; Muller, T; Hammond, E; Dunn, D; Negro, F; Bochud, P; Mallal, S; Ahlenstiel, G; Stewart, GJ; George, J; Booth, DR.

In: PLoS Medicine, Vol. 8, No. 9, 2011, p. 1-8.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - IL28B, HLA-C and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a european cohort: A cross-sectional study

AU - Suppiah, V

AU - Gaudieri, Silvana

AU - Armstrong, NJ

AU - O'Connor, KS

AU - Berg, T

AU - Weltman, M

AU - Abate, ML

AU - Spengler, U

AU - Bassendine, M

AU - Dore, GJ

AU - Irving, W

AU - Powell, E

AU - Hellard, M

AU - Riordan, S

AU - Matthews, G

AU - Sheridan, D

AU - Nattermann, J

AU - Smedile, A

AU - Muller, T

AU - Hammond, E

AU - Dunn, D

AU - Negro, F

AU - Bochud, P

AU - Mallal, S

AU - Ahlenstiel, G

AU - Stewart, GJ

AU - George, J

AU - Booth, DR

PY - 2011

Y1 - 2011

U2 - 10.1371/journal.pmed.1001092

DO - 10.1371/journal.pmed.1001092

M3 - Article

C2 - 21931540

VL - 8

SP - 1

EP - 8

JO - PLoS Medicine

JF - PLoS Medicine

SN - 1549-1277

IS - 9

ER -